Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Salvador, Juvés"'
Autor:
Irene López-González, Selene Lomoio, Margarita Carmona, Jesús Moreno, Aurora Pujol, Isidro Ferrer, Mario Díaz, Laura Joda, Ester Aso, Reinald Pamplona, Virginia Martín, Núria Fernández-Yagüe, Salvador Juvés, Manuel Portero-Otin
Publikováno v:
Brain Pathology. 22:636-653
Double-transgenic amyloid precursor protein/presenilin 1 (APP/PS1) mice express a chimeric mouse/human APP bearing the Swedish mutation (Mo/HuAPP695swe) and a mutant human PS1-dE9 both causative of familial Alzheimer's disease (FAD). Transgenic mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd5b5c8d543e6023cac77ce107dd36e
https://doi.org/10.1111/j.1750-3639.2011.00560.x
https://doi.org/10.1111/j.1750-3639.2011.00560.x
Publikováno v:
The American Journal of Pathology. 171:1312-1323
Myotilinopathy is a subgroup of myofibrillar myopathies caused by mutations in the myotilin gene in which there is aggregation of abnormal cytoskeletal proteins and ubiquitin. We report here on the accumulation of neuron-related proteins such as ubiq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a25d1a215b92468ca1a717c0b603614
https://doi.org/10.2353/ajpath.2007.070520
https://doi.org/10.2353/ajpath.2007.070520
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
The specific CB2 cannabinoid receptor agonist JWH-133 induced cognitive improvement in double AβPP/PS1 transgenic mice, a genetic model of Alzheimer's disease. This effect was more pronounced when administered at the pre-symptomatic rather than the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bca9df6b19aa8466109cde59a64f274
http://hdl.handle.net/2445/69200
http://hdl.handle.net/2445/69200
Autor:
Ester Aso, Isidro Ferrer, Ernest Palomer, Salvador Juvés, Rafael Maldonado, Francisco J. Muñoz
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
The present study shows that chronic administration of the cannabinoid receptor type 1 (CB1) receptor agonist arachidonyl-2-chloroethylamide (ACEA) at pre-symptomatic or at early symptomatic stages, at a non-amnesic dose, reduces the cognitive impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0803be1df0e242766a412cb1c4d249dc
https://pubmed.ncbi.nlm.nih.gov/22451318
https://pubmed.ncbi.nlm.nih.gov/22451318
Autor:
Ester, Aso, Selene, Lomoio, Irene, López-González, Laura, Joda, Margarita, Carmona, Núria, Fernández-Yagüe, Jesús, Moreno, Salvador, Juvés, Aurora, Pujol, Reinald, Pamplona, Manuel, Portero-Otin, Virginia, Martín, Mario, Díaz, Isidro, Ferrer
Publikováno v:
Brain Pathol
Double‐transgenic amyloid precursor protein/presenilin 1 (APP/PS1) mice express a chimeric mouse/human APP bearing the Swedish mutation (Mo/HuAPP695swe) and a mutant human PS1‐dE9 both causative of familial Alzheimer's disease (FAD). Transgenic m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a603417101bc45b6eb557587c43ac454
https://pubmed.ncbi.nlm.nih.gov/22188425
https://pubmed.ncbi.nlm.nih.gov/22188425
Publikováno v:
Alzheimer's & Dementia. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd9514486574b2b84be80f4c5e1e5fd3
https://doi.org/10.1016/j.jalz.2010.05.1894
https://doi.org/10.1016/j.jalz.2010.05.1894